PEERS Program for Opioid Use Disorder
(PEERS Trial)
Trial Summary
What is the purpose of this trial?
The goal of this pilot study is to evaluate the feasibility and acceptability of implementing a peer recovery support program to support patient engagement in medication treatment for opioid use disorder (MOUD). The program, entitled "Promoting Enhanced Engagement through Recovery Support" (PEERS) was developed in collaboration with community and clinical partners for the MOUD outpatient setting. Information gathered during this pilot study will inform refinements to the program and study components for a future clinical trial that will evaluate the effectiveness of the peer recovery support program in increasing patient retention in MOUD. The investigators will recruit 12 participants to the pilot study, all of whom will receive the PEERS program. The study will take place in Geisinger outpatient addiction treatment clinics in northeast Pennsylvania. Patients initiating MOUD treatment at one of the clinics will be eligible for participation, and will be recruited via email, patient portal messages, and phone. Each participant will receive the PEERS program, entailing regular sessions with a Certified Recovery Specialist (CRS) for 6 months. Participants will also be asked to complete assessments at baseline and 12 weeks and will be invited to provide qualitative feedback on their experience with the program through an interview conducted between 8-12 weeks. As the focus of the pilot pertains to the feasibility and acceptability of the program and the study components, study outcomes focus on participant engagement in and acceptance of the program, CRS fidelity to the program, barriers to implementation, and feasibility of data collection.
Do I need to stop my current medications to join the trial?
The trial protocol does not specify whether you need to stop taking your current medications. However, since the study focuses on supporting patients already on medication for opioid use disorder, it seems likely that you can continue your current treatment.
What data supports the effectiveness of the PEERS Program treatment for opioid use disorder?
Research shows that peer recovery support services, which are part of the PEERS Program, can help people with opioid use disorder by engaging them in treatment and reducing relapse. Peer support models have been successful in both clinical and community settings, suggesting that having someone with similar experiences can be beneficial in recovery.12345
How is the PEERS Program treatment for opioid use disorder different from other treatments?
The PEERS Program is unique because it involves peer support, where individuals with personal experience in recovery help others with opioid use disorder. This approach focuses on connecting patients to recovery services and providing ongoing support, which is different from traditional medical treatments that primarily rely on medication.12356
Research Team
Melissa Poulsen, PhD
Principal Investigator
Geisinger Clinic
Eligibility Criteria
This trial is for adults over 18 who have recently started medication treatment for opioid use disorder at specific outpatient clinics. Participants must be willing to engage in the PEERS program and able to give consent.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the PEERS program, entailing regular sessions with a Certified Recovery Specialist for 6 months
Assessment
Participants complete assessments at baseline and 12 weeks, and provide qualitative feedback through an interview conducted between 8-12 weeks
Follow-up
Participants are monitored for engagement and acceptability of the program, and CRS fidelity to the program
Treatment Details
Interventions
- PEERS Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Geisinger Clinic
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
UConn Health
Collaborator